SYK · Stryker Corporation
$331.542026-05-17Sector: Healthcare; Industry: Medical - Devices; Sub-Industry: Health Care Equipment
Intrinsic Value Range Comparison · Mulya.ai
R&D capitalized (5yr)Base · active
$167
-49.6% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($156 · $172) Analysts Range ($390 · $469) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2021.Q4 | $17.1B | — | 24.2% | 12.6% | $3.6B | −$2MM | $3.6B | 6.6% | — | 13.2% | $27.5B | $5.16 | — |
| 2022.Q4 | $18.4B | 7.8% | 22.3% | 12.1% | $3.6B | −$3.3B | $286MM | 7.8% | — | 12.3% | $31.1B | $6.10 | — |
| 2023.Q4 | $20.5B | 11.1% | 23.0% | 13.8% | $4.1B | −$1.2B | $2.9B | 7.6% | — | 12.8% | $32.1B | $8.19 | — |
| 2024.Q4 | $22.6B | 10.2% | 24.7% | 14.3% | $4.8B | −$2.5B | $2.3B | 8.2% | — | 14.5% | $33.6B | $7.74 | — |
| 2025.Q4 | $25.1B | 11.2% | 24.7% | 28.1% | $4.5B | −$4.6B | −$115MM | 8.1% | — | 12.6% | $37.4B | $8.40 | 20.7 |
| italics below = DCF projection · 10yr Rev CAGR: 7.1% |
| 2026.Q4 | $27.3B | +8.9% | 21.5% | 27.3% | $4.3B | −$3.4B | $872MM | 8.0% | $808MM | 10.9% | $40.8B | $10.03 | 33.1 |
| 2027.Q4 | $29.6B | +8.4% | 22.3% | 26.5% | $4.9B | −$3.6B | $1.3B | 8.1% | $1.1B | 11.4% | $44.4B | $11.42 | 29.0 |
| 2028.Q4 | $32.2B | +8.5% | 23.1% | 25.7% | $5.5B | −$4.1B | $1.5B | 8.1% | $1.2B | 11.9% | $48.4B | $13.00 | 25.5 |
| 2029.Q4 | $35.1B | +9.1% | 24.1% | 24.9% | $6.4B | −$4.8B | $1.5B | 8.2% | $1.1B | 12.5% | $53.2B | $14.94 | 22.2 |
| 2030.Q4 | $37.9B | +8.1% | 24.1% | 24.1% | $6.9B | −$4.8B | $2.1B | 8.3% | $1.5B | 12.5% | $58.0B | $16.32 | 20.3 |
|
| Term. Yr+ | $52.1B | 4.1% | 19.8% | 20.0% | $8.2B | −$2.6B | $5.7B | 8.6% | $56.7B | 13.1% | — | — | — |
Active scenario IV: $167 (-49.6% vs market)